Cassava Confirms Mechanism of Action of Simufilam, Novel Drug Candidate for Alzheimer’s

 

• New cell biology data from Europe shows simufilam interrupts a pathogenic signaling pathway in Alzheimer’s disease.
• Results corroborate prior research from other academic researchers.
• These data once again confirm the biological activity of simufilam.

https://www.biospace.com/article/releases/cassava-sciences-announces-science-publication-that-confirms-mechanism-of-action-of-simufilam-a-novel-drug-candidate-for-people-with-alzheimer-s-disease/